EUDA Health Ownership

EUDA Stock   4.32  0.07  1.59%   
EUDA Health holds a total of 37.15 Million outstanding shares. EUDA Health Holdings retains substantial amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as EUDA Health in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of EUDA Health, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
As of November 29, 2024, Dividends Paid is expected to decline to about 1 M. The current year's Dividend Paid And Capex Coverage Ratio is expected to grow to about (554.4 K). As of November 29, 2024, Common Stock Shares Outstanding is expected to decline to about 17.7 M. The current year's Net Loss is expected to grow to about (21.3 M).
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EUDA Health Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

EUDA Stock Ownership Analysis

About 49.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.62. EUDA Health Holdings had not issued any dividends in recent years. To learn more about EUDA Health Holdings call Wei Chen at 65 6268 6821 or check out https://euda.com.
Besides selling stocks to institutional investors, EUDA Health also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different EUDA Health's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align EUDA Health's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

EUDA Health Quarterly Liabilities And Stockholders Equity

1.31 Million

About 49.0% of EUDA Health Holdings are currently held by insiders. Unlike EUDA Health's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against EUDA Health's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of EUDA Health's insider trades

EUDA Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as EUDA Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading EUDA Health Holdings backward and forwards among themselves. EUDA Health's institutional investor refers to the entity that pools money to purchase EUDA Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Hudson Bay Capital Management Lp2024-09-30
800 K
Citadel Advisors Llc2024-09-30
33.8 K
Walleye Trading Advisors, Llc2024-06-30
16.6 K
Geode Capital Management, Llc2024-09-30
16 K
Ubs Group Ag2024-06-30
10.6 K
Yakira Capital Management, Inc.2024-06-30
0.0
Renaissance Technologies Corp2024-06-30
0.0
Wolverine Asset Management Llc2024-06-30
0.0
Xtx Topco Ltd2024-06-30
0.0
Note, although EUDA Health's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

EUDA Health Holdings Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific EUDA Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on EUDA Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases EUDA Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

EUDA Health Corporate Filings

30th of October 2024
Other Reports
ViewVerify
6K
18th of October 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
9th of May 2024
Other Reports
ViewVerify
13A
27th of March 2024
The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934
ViewVerify

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether EUDA Health Holdings is a strong investment it is important to analyze EUDA Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact EUDA Health's future performance. For an informed investment choice regarding EUDA Stock, refer to the following important reports:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EUDA Health Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EUDA Health. If investors know EUDA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EUDA Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.62)
Revenue Per Share
0.144
Quarterly Revenue Growth
(0.14)
Return On Assets
(0.86)
The market value of EUDA Health Holdings is measured differently than its book value, which is the value of EUDA that is recorded on the company's balance sheet. Investors also form their own opinion of EUDA Health's value that differs from its market value or its book value, called intrinsic value, which is EUDA Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EUDA Health's market value can be influenced by many factors that don't directly affect EUDA Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EUDA Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if EUDA Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EUDA Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.